Literature DB >> 11242048

Aberrant CFTR-dependent HCO3- transport in mutations associated with cystic fibrosis.

J Y Choi1, D Muallem, K Kiselyov, M G Lee, P J Thomas, S Muallem.   

Abstract

Cystic fibrosis (CF) is a disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Initially, Cl- conductance in the sweat duct was discovered to be impaired in CF, a finding that has been extended to all CFTR-expressing cells. Subsequent cloning of the gene showed that CFTR functions as a cyclic-AMP-regulated Cl- channel; and some CF-causing mutations inhibit CFTR Cl- channel activity. The identification of additional CF-causing mutants with normal Cl- channel activity indicates, however, that other CFTR-dependent processes contribute to the disease. Indeed, CFTR regulates other transporters, including Cl(-)-coupled HCO3- transport. Alkaline fluids are secreted by normal tissues, whereas acidic fluids are secreted by mutant CFTR-expressing tissues, indicating the importance of this activity. HCO3- and pH affect mucin viscosity and bacterial binding. We have examined Cl(-)-coupled HCO3- transport by CFTR mutants that retain substantial or normal Cl- channel activity. Here we show that mutants reported to be associated with CF with pancreatic insufficiency do not support HCO3- transport, and those associated with pancreatic sufficiency show reduced HCO3- transport. Our findings demonstrate the importance of HCO3- transport in the function of secretory epithelia and in CF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11242048      PMCID: PMC3943212          DOI: 10.1038/35065099

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  29 in total

1.  Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound glibenclamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator.

Authors:  C M McNicholas; W B Guggino; E M Schwiebert; S C Hebert; G Giebisch; M E Egan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

2.  Disease-associated mutations in cytoplasmic loops 1 and 2 of cystic fibrosis transmembrane conductance regulator impede processing or opening of the channel.

Authors:  F S Seibert; Y Jia; C J Mathews; J W Hanrahan; J R Riordan; T W Loo; D M Clarke
Journal:  Biochemistry       Date:  1997-09-30       Impact factor: 3.162

3.  Cytoplasmic loop three of cystic fibrosis transmembrane conductance regulator contributes to regulation of chloride channel activity.

Authors:  F S Seibert; P Linsdell; T W Loo; J W Hanrahan; J R Riordan; D M Clarke
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

4.  Disease-associated mutations in the fourth cytoplasmic loop of cystic fibrosis transmembrane conductance regulator compromise biosynthetic processing and chloride channel activity.

Authors:  F S Seibert; P Linsdell; T W Loo; J W Hanrahan; D M Clarke; J R Riordan
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

5.  Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties.

Authors:  D N Sheppard; D P Rich; L S Ostedgaard; R J Gregory; A E Smith; M J Welsh
Journal:  Nature       Date:  1993-03-11       Impact factor: 49.962

6.  CFTR as a cAMP-dependent regulator of sodium channels.

Authors:  M J Stutts; C M Canessa; J C Olsen; M Hamrick; J A Cohn; B C Rossier; R C Boucher
Journal:  Science       Date:  1995-08-11       Impact factor: 47.728

7.  Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly rectified chloride currents.

Authors:  S B Fulmer; E M Schwiebert; M M Morales; W B Guggino; G R Cutting
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

8.  cAMP-regulated whole cell chloride currents in pancreatic duct cells.

Authors:  M A Gray; S Plant; B E Argent
Journal:  Am J Physiol       Date:  1993-03

9.  Regulation by ATP and ADP of CFTR chloride channels that contain mutant nucleotide-binding domains.

Authors:  M P Anderson; M J Welsh
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

10.  Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator.

Authors:  J H Poulsen; H Fischer; B Illek; T E Machen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more
  104 in total

Review 1.  Value of genetic testing in the management of pancreatitis.

Authors:  D C Whitcomb
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 2.  Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion.

Authors:  Min Goo Lee; Ehud Ohana; Hyun Woo Park; Dongki Yang; Shmuel Muallem
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

3.  Sparkling water--bicarbonate for cervix and cystic fibrosis.

Authors:  Gunnar C Hansson
Journal:  J Physiol       Date:  2010-08-01       Impact factor: 5.182

Review 4.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

5.  Restoration of CFTR Activity in Ducts Rescues Acinar Cell Function and Reduces Inflammation in Pancreatic and Salivary Glands of Mice.

Authors:  Mei Zeng; Mitchell Szymczak; Malini Ahuja; Changyu Zheng; Hongen Yin; William Swaim; John A Chiorini; Robert J Bridges; Shmuel Muallem
Journal:  Gastroenterology       Date:  2017-06-19       Impact factor: 22.682

6.  Localization studies of rare missense mutations in cystic fibrosis transmembrane conductance regulator (CFTR) facilitate interpretation of genotype-phenotype relationships.

Authors:  Kristina V Krasnov; Maria Tzetis; Jie Cheng; William B Guggino; Garry R Cutting
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

Review 7.  Interactions of connexins with other membrane channels and transporters.

Authors:  Marc Chanson; Basilio A Kotsias; Camillo Peracchia; Scott M O'Grady
Journal:  Prog Biophys Mol Biol       Date:  2007-03-14       Impact factor: 3.667

8.  Role of Ca2+ -activated ion transport in the treatment of cystic fibrosis.

Authors:  Akos Zsembery; Dóra Hargitai
Journal:  Wien Med Wochenschr       Date:  2008

9.  Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis.

Authors:  Shigeru B H Ko; Nobumasa Mizuno; Yasushi Yatabe; Toshiyuki Yoshikawa; Hiroshi Ishiguro; Akiko Yamamoto; Sakiko Azuma; Satoru Naruse; Kenji Yamao; Shmuel Muallem; Hidemi Goto
Journal:  Gastroenterology       Date:  2010-01-15       Impact factor: 22.682

Review 10.  The Clinical Biology of Cystic Fibrosis Transmembrane Regulator Protein: Its Role and Function in Extrapulmonary Disease.

Authors:  Theodore G Liou
Journal:  Chest       Date:  2018-10-22       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.